Related references
Note: Only part of the references are listed.Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients
Monica Gelzo et al.
SCIENTIFIC REPORTS (2022)
A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity
Kunwar Singh et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)
Multi-organ proteomic landscape of COVID-19 autopsies
Xiu Nie et al.
CELL (2021)
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients
Carolina D'Avila-Mesquita et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Soluble HLA-G is upregulated in serum of patients with severe COVID-19
Noor T. Al-Bayatee et al.
HUMAN IMMUNOLOGY (2021)
COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas
Xianwen Ren et al.
CELL (2021)
Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections
Srinivasa Reddy Bonam et al.
NANO TODAY (2021)
sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity
Pedro V. da Silva-Neto et al.
VIRUSES-BASEL (2021)
COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes
Thais Fernanda de Campos Fraga-Silva et al.
FRONTIERS IN IMMUNOLOGY (2021)
Single-cell multi-omics analysis of the immune response in COVID-19
Emily Stephenson et al.
NATURE MEDICINE (2021)
Dysregulation of Pulmonary Responses in Severe COVID-19
Dandan Wu et al.
VIRUSES-BASEL (2021)
Estimating the early impact of vaccination against COVID-19 on deaths among elderly people in Brazil: Analyses of routinely-collected data on vaccine coverage and mortality
Cesar Victora et al.
ECLINICALMEDICINE (2021)
Oxidative stress – A unifying paradigm in hypertension
Rhian M. Touyz et al.
CANADIAN JOURNAL OF CARDIOLOGY (2020)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
Dominic Wichmann et al.
ANNALS OF INTERNAL MEDICINE (2020)
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Thomas Menter et al.
HISTOPATHOLOGY (2020)
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
Jingyuan Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George et al.
LANCET RESPIRATORY MEDICINE (2020)
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series
Pavan K. Bhatraju et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19
Teluguakula Narasaraju et al.
FRONTIERS IN PHARMACOLOGY (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study
Jianfeng Xie et al.
INTENSIVE CARE MEDICINE (2020)
Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome
Rana Kadry et al.
Infectious Disorders - Drug Targets (2020)
Matrix metalloproteinase-2-induced epidermal growth factor receptor transactivation impairs redox balance in vascular smooth muscle cells and facilitates vascular contraction
Alejandro F. Prado et al.
REDOX BIOLOGY (2018)
Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors
G. Weiss et al.
MUCOSAL IMMUNOLOGY (2017)
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
Dimitrios Tsikas
ANALYTICAL BIOCHEMISTRY (2017)
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
Fabio Morandi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients
Carlos Fernandez-Patron et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Reactive Oxygen Species in Inflammation and Tissue Injury
Manish Mittal et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
New insights into HLA-G mediated tolerance
G. Amodio et al.
TISSUE ANTIGENS (2014)
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding
Roberta Rizzo et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2013)
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
Richard S. Hotchkiss et al.
LANCET INFECTIOUS DISEASES (2013)
Polymorphic Sites at the 3′ Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population
Gustavo Martelli-Palomino et al.
PLOS ONE (2013)
Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics
David Rodriguez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
MYD88-dependent and -independent activation of TREM-1 via specific TLR ligands
Heng Zheng et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Assessment of Vascular Effects of Tamoxifen and Its Metabolites on the Rat Perfused Hindquarter Vascular Bed
Marcelo F. Montenegro et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Activation and modulation of 72 kDa matrix metalloproteinase-2 by peroxynitrite and glutathione
Serena Viappiani et al.
BIOCHEMICAL PHARMACOLOGY (2009)
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
S. McKeown et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
The epithelium in acute lung injury/acute respiratory distress syndrome
Michael A. Groppera et al.
CURRENT OPINION IN CRITICAL CARE (2008)
Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation
Philippe Van Lint et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes
Vanesa Gomez-Pina et al.
JOURNAL OF IMMUNOLOGY (2007)
Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted
Kendra J. Greenlee et al.
PHYSIOLOGICAL REVIEWS (2007)
Matrix metalloproteinases and the regulation of tissue remodelling
Andrea Page-McCaw et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Increase in HLA-G1 proteolytic shedding by tumor cells:: a regulatory pathway controlled by NF-κB inducers
I. Zidi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Matrix metalloproteinases (MMPs) in health and disease: an overview
CJ Malemud
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Matrix metalloproteinases in destructive pulmonary pathology
PTG Elkington et al.
THORAX (2006)
Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells
K Migita et al.
FEBS LETTERS (2005)
Different roles for matrix metalloproteinase-2 and matrix metalloproteinase-9 in the pathogenesis of cardiac allograft rejection
LG Campbell et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Matrix metalloproteinases as modulators of inflammation and innate immunity
WC Parks et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase
CA Owen et al.
JOURNAL OF IMMUNOLOGY (2004)
Neutrophil granules and secretory vesicles in inflammation
M Faurschou et al.
MICROBES AND INFECTION (2003)
Soluble nonclassical HLA generated by the metalloproteinase pathway
YZ Dong et al.
HUMAN IMMUNOLOGY (2003)
Matrix metalloproteinase-9 in lung remodeling
JJ Atkinson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency
DB Corry et al.
NATURE IMMUNOLOGY (2002)
Matrix metalloproteinases in vascular remodeling and atherogenesis - The good, the bad, and the ugly
ZS Galis et al.
CIRCULATION RESEARCH (2002)
Matrix metalloproteinases-2,-8, and-9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress
K Cederqvist et al.
PEDIATRICS (2001)
Matrix metalloproteinases in lung biology
WC Parks et al.
RESPIRATORY RESEARCH (2001)
Bronchoalveolar lavage and tracheal aspirate for assessing airway inflammation in children
MD Shields et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
